ReportGem ReportGem 中文

REAL-TIME GLOBAL RESEARCH

Reiterating Healthcare, Risk/Reward Attractive, High Conviction Franchise and Innovation Ideas; Pricing cycle starting to pick up pace, increasing earnings expectations for corrugators; Upgrade International Paper to better risk/reward set-up; 2Q26 Post M

Published: 2026-07-28Institution: JPMorganPages: 20Original language: EnglishEvidence page: 1

Research evidence excerpt

Reiterating Healthcare, Risk/Reward Attractive, High Conviction Franchise and Innovation Ideas; Pricing cycle starting to pick up pace, increasing earnings expectations for corrugators; Upgrade International Paper to better risk/reward set-up; 2Q26 Post M

North America Equity Research

U.S. First to Market 28 July 2026

Top Stories

Equity Thematic Strategy (Dubravko Lakos-Bujas/Bhupinder Singh/Kamal Tamboli)

Reiterating Healthcare, Risk/Reward Attractive, High Conviction Franchise and Innovation Ideas

Healthcare offers a rare combination of durable growth, Technology-like profitability, attractive valuation and diversification

benefits at a time when many investors remain heavily concentrated in the AI theme. For much of the past three years, investor

capital has been singularly focused on AI and AI-adjacent themes, leaving one of the market’s largest and most durable growth

sectors increasingly overlooked.

AFL | | Paper & Packaging (Detlef Winckelmann)

Pricing cycle starting to pick up pace, increasing earnings expectations for corrugators; Upgrade

International Paper on better risk/reward set-up

Last Friday, Green Markets reported that PKG had announced a price increase of $140/t for US kraftliner, to be implemented

on 1 September 2026 (read first take here). While we think that a full implementation is unlikely, we take this opportunity to

address a couple of key debates. In this note, we discuss: (1) the current and implied price/cost potential of the US linerboard

market, (2) where we think prices should settle after considering the incentive price needed to add new capacity, (3) what this

price increase means for valuations, and (4) how this impacts peer companies differently.

Baker Hughes (Arun Jayaram) (BKR, OW, PT $74.00)

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer